- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03003819
A Comparison of Two Socket Sealing Collagen Matrices for Extraction Socket Management
February 18, 2020 updated by: McGuire Institute
A Prospective, Randomized, Controlled, Multi-center Evaluation of Extraction Socket Management Comparing Two Socket Sealing Collagen Matrices
A prospective RCT of intact extractions with delayed implant placement comparing extraction socket management effectiveness and office economics of two collagen matrices.
Soft tissue wound healing will be assessed out to 4-months post-operative, when implants will be placed.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
A prospective, randomized, multi-center, controlled clinical study of intact extractions (bony dehiscences <1/3 socket apico-coronal and mesial-distal dimension) with delayed implant placement.
Study objective: to compare extraction socket management effectiveness and office economics of a frequently used wound dressing (control) with a soft tissue augmentation matrix (test) in 32-64 subjects 18 -75 years of age with intact (bony dehiscence, if present, < 1/3 socket dimension) extractions intended for dental implant replacement.
Following screening subjects will undergo tooth extraction and randomization to either the control or test therapy.
After treatment, subjects will be followed until 4- months, the time of implant placement.
Primary outcome: soft tissue wound healing measured by (1) gap closure and (2) graft containment at all time points.
Study Type
Interventional
Enrollment (Anticipated)
64
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Michigan
-
Fenton, Michigan, United States, 48430
- Recruiting
- Seven Lakes Periodontics
-
Contact:
- Diego Velasquez, DDS, MSD
- Phone Number: 810-750-3400
- Email: Periomichigan@gmail.com
-
Sub-Investigator:
- Rick Heard, DDS
-
Sub-Investigator:
- Jim Janakievski, DDS
-
Sub-Investigator:
- Marc Nevins, DDS
-
Sub-Investigator:
- Brian Pope, DDS
-
Sub-Investigator:
- Gregory Toback, DDS
-
Sub-Investigator:
- Chris Richardson, DMD
-
Principal Investigator:
- Diego Velasquez, DDS, MSD
-
Sub-Investigator:
- Don Clem, DDS
-
Sub-Investigator:
- Michael Pikos, DDS
-
Sub-Investigator:
- Pamela McClain, DDS
-
Sub-Investigator:
- Michael McGuire, DDS
-
Sub-Investigator:
- Craig Misch, DDS, MDS
-
Principal Investigator:
- Greg Santarelli, DDS
-
Sub-Investigator:
- Rachel Schallhorn, DDS, MS
-
Sub-Investigator:
- Eric T Scheyer, DDS, MS
-
Sub-Investigator:
- Stephen Pickering, DDS, MSD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subject indicated for anterior tooth extraction (from premolars forward) intended for implant placement.
- Subjects with essentially intact extraction sockets - bony dehiscences < 1/3 the depth of socket and mesial-distal width of tooth socket
- Subjects will have read, understood and signed an institutional review board (IRB) approved Informed Consent Form (ICF).
- Subjects must be able and willing to follow study procedures and instructions
Exclusion Criteria:
- Subjects with healing disorders (i.e., diabetes mellitus, cancer, HIV, bone metabolic diseases) that could compromise wound healing and/ or preclude implant surgery; or who are currently receiving or have received within two months prior to study entry, systemic corticosteroids, immunosuppressive agents, radiation therapy, and/or chemotherapy which could compromise wound healing and preclude periodontal surgery.
- Subjects taking intramuscular or intravenous bisphosphonates.
- Subjects who have a known allergy or sensitivity to collagen.
- Subjects with acute, suppurative lesions with pain, swelling and apical lesions > 5mm will be excluded, though antibiotic prophylaxis may be employed to reduce infection and provide possible subject reconsideration for inclusion.
- Heavy smokers/tobacco users defined as those smoking ≥ 10 cigarettes or ≥ 4 cigars or ≥ 4 pipes per day. For non-heavy smokers, smoking ≥ 10 cigarettes or ≥ 4 cigars or ≥ 4 pipes per day is prohibited for the duration of the study.
- Female subjects who are pregnant or lactating, or who intend to become pregnant during the study duration
- Subjects participating in other clinical studies involving therapeutic intervention (either medical or dental).
- Subjects, who in the opinion of the Investigator, for any reason other than those listed above, will not be able to complete the study per protocol.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Control Collagen Wound Dressing
Bovine collagen sponge used to control bleeding, stabilize blood clots and protect dental wounds
|
Following resolution of any periodontal issues in the region of study and administration of pre-surgical antibiotic and local anesthetic, minimally traumatic extraction will be performed with periotomes .
After degranulation and bone graft placement, control or test biomaterial will be placed according to the randomization schedule and surgical instructions for each biomaterial.
|
|
Active Comparator: Test Collagen Matrix
Bilayer, porcine collagen matrix for soft tissue regeneration used as a socket seal in extraction socket grafting
|
Following resolution of any periodontal issues in the region of study and administration of pre-surgical antibiotic and local anesthetic, minimally traumatic extraction will be performed with periotomes .
After degranulation and bone graft placement, control or test biomaterial will be placed according to the randomization schedule and surgical instructions for each biomaterial.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Socket Soft Tissue Gap Closure - linear measures buccal-lingual in millimeters
Time Frame: 4-months
|
Longitudinal extraction socket soft tissue gap closure measured buccal-lingual from baseline to 4-months.
|
4-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Socket Soft Tissue Gap Closure - linear measures mesial-distal
Time Frame: 4-months
|
Longitudinal extraction socket soft tissue gap closure measured mesial-distal from baseline to 4-months.
|
4-months
|
|
Graft Containment as observed by subject and examiner (yes/ no)
Time Frame: 4-months
|
4-months
|
|
|
Inflammation Score (Loe and Sillness)
Time Frame: 4-months
|
4-months
|
|
|
Biomaterial Integrity - 4-point scale
Time Frame: 4-months
|
Score 0-4, 0 = biomaterial completely present, 4 = no evidence of biomaterial/ complete granulation or other tissue
|
4-months
|
|
Tissue Thickness - probe show-thru at baseline and biopsy measure in millimeters at 4-months
Time Frame: 4-months
|
Soft tissue thickness is measured using probe "show-thru" (tissue transparency) at baseline and soft tissue biopsy at the implant site immediately prior to implant placement
|
4-months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Todd V Scantlebury, BS, The McGuire Institute
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Thoma DS, Sancho-Puchades M, Ettlin DA, Hammerle CH, Jung RE. Impact of a collagen matrix on early healing, aesthetics and patient morbidity in oral mucosal wounds - a randomized study in humans. J Clin Periodontol. 2012 Feb;39(2):157-65. doi: 10.1111/j.1600-051X.2011.01823.x. Epub 2011 Dec 6.
- Sclar AG. Strategies for management of single-tooth extraction sites in aesthetic implant therapy. J Oral Maxillofac Surg. 2004 Sep;62(9 Suppl 2):90-105. doi: 10.1016/j.joms.2004.06.041. Erratum In: J Oral Maxillofac Surg. 2005 Jan;63(1):158.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2016
Primary Completion (Anticipated)
April 1, 2020
Study Completion (Anticipated)
June 1, 2020
Study Registration Dates
First Submitted
December 18, 2016
First Submitted That Met QC Criteria
December 22, 2016
First Posted (Estimate)
December 28, 2016
Study Record Updates
Last Update Posted (Actual)
February 20, 2020
Last Update Submitted That Met QC Criteria
February 18, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GPNA0001-2016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tooth Loss
-
Erasmus Medical CenterUniversity Medical Center Groningen; University of Santiago de CompostelaRecruitingTooth Loss / RehabilitationNetherlands
-
Institut Straumann AGCompleted
-
University of BelgradeInstitute Straumann AG, Basel, SwitzerlandActive, not recruitingTooth Loss / Rehabilitation | MaxillaSerbia
-
Universidad Complutense de MadridRecruitingPartial Edentulism | Tooth Loss / RehabilitationSpain
-
Duygu KarasanHacettepe UniversityCompleted
-
Murad AlrashidiNot yet recruitingSpace Maintenance | Tooth Loss / RehabilitationSaudi Arabia
-
University of AarhusCompleted
-
University of GuarulhosCompletedTooth Decay | Tooth Loss / Rehabilitation | Caries Active
-
Akdeniz UniversityCompletedAlveolar Bone Loss | Tooth Loss / RehabilitationTurkey (Türkiye)
-
Cairo UniversityNot yet recruitingLoss of Teeth Due to ExtractionEgypt
Clinical Trials on Control Collagen Wound Dressing
-
Maxigen Biotech Inc.RecruitingBreast Tumors | Wound Healing | Collagen Wound DressingTaiwan
-
Maxigen Biotech Inc.CompletedBurn Wound | Venous Ulcers | Bedsores | Diabetic Foot Wound
-
Medline IndustriesWithdrawn
-
NeXtGen Biologics, Inc.State University of New York at BuffaloCompletedAllergy | Dermatitis, Allergic Contact | Allergy SkinUnited States
-
The University of Texas Health Science Center at...Completed
-
Centro Hospitalar do Tâmega e SousaActive, not recruitingSurgical Wound | Surgical Wound Infection | Surgical Site Infection | Surgical Wound, Healed | Surgical Complication | Surgical Wound Dehiscence | Surgical Wound HaemorrhagePortugal
-
The University of Texas Health Science Center,...CompletedPain From Free Gingival GraftUnited States
-
UPM BiomedicalsUniversity of HelsinkiCompleted
-
ULURU Inc.United States Department of DefenseRecruitingPressure Ulcers Stage II | Pressure Ulcers Stage III | Pressure Ulcer, Stage IVUnited States
-
Princess Margaret Hospital, Hong KongUnknownSurgical Site InfectionHong Kong